Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

EXOSC9 anticorps

Cet anticorps anti-EXOSC9 est un anticorps Lapin Polyclonal détectant EXOSC9 dans WB, ELISA, IHC et IF. Adapté pour Humain.
N° du produit ABIN7114017

Aperçu rapide pour EXOSC9 anticorps (ABIN7114017)

Antigène

Voir toutes EXOSC9 Anticorps
EXOSC9 (Exosome Component 9 (EXOSC9))

Reactivité

  • 15
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
Humain

Hôte

  • 12
  • 2
  • 1
Lapin

Clonalité

  • 13
  • 2
Polyclonal

Conjugué

  • 8
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp EXOSC9 est non-conjugé

Application

  • 6
  • 3
  • 1
  • 1
  • 1
Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)
  • Fonction

    EXOSC9 antibody

    Purification

    Immunogen affinity purified

    Pureté

    ≥95 % as determined by SDS-PAGE

    Immunogène

    exosome component 9

    Isotype

    IgG
  • Indications d'application

    WB: 1:500-1:2000, IHC: 1:20-1:200, IF: 1:20-1:200

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Conseil sur la manipulation

    Avoid repeated freeze / thaw cycles.

    Stock

    -20 °C

    Stockage commentaire

    -20°C for 12 months

    Date de péremption

    12 months
  • Antigène

    EXOSC9 (Exosome Component 9 (EXOSC9))

    Autre désignation

    EXOSC9

    Sujet

    Synonyms: Exosome complex component RRP45|Autoantigen PM/Scl 1|Exosome component 9|P75 polymyositis-scleroderma overlap syndrome-associated autoantigen|Polymyositis/scleroderma autoantigen 1|Polymyositis/scleroderma autoantigen 75 kDa (PM/Scl-75)|EXOSC9|PMSCL1

    Background: Non-catalytic component of the RNA exosome complex which has 3'->5' exoribonuclease activity and participates in a multitude of cellular RNA processing and degradation events. In the nucleus, the RNA exosome complex is involved in proper maturation of stable RNA species such as rRNA, snRNA and snoRNA, in the elimination of RNA processing by-products and non-coding 'pervasive' transcripts, such as antisense RNA species and promoter-upstream transcripts(PROMPTs), and of mRNAs with processing defects, thereby limiting or excluding their export to the cytoplasm. The RNA exosome may be involved in Ig class switch recombination(CSR) and/or Ig variable region somatic hypermutation(SHM) by targeting AICDA deamination activity to transcribed dsDNA substrates. In the cytoplasm, the RNA exosome complex is involved in general mRNA turnover and specifically degrades inherently unstable mRNAs containing AU-rich elements(AREs) within their 3' untranslated regions, and in RNA surveillance pathways, preventing translation of aberrant mRNAs. It seems to be involved in degradation of histone mRNA. The catalytic inactive RNA exosome core complex of 9 subunits(Exo-9) is proposed to play a pivotal role in the binding and presentation of RNA for ribonucleolysis, and to serve as a scaffold for the association with catalytic subunits and accessory proteins or complexes. EXOSC9 binds to ARE-containing RNAs.

    Poids moléculaire

    65 kDa

    ID gène

    5393

    UniProt

    Q06265
Vous êtes ici:
Chat with us!